ArticleMethods in molecular biology (Clifton, N.J.)2025
Methods for Assessing Scaffold Vascularization with Human Endothelial Cells.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The success of tissue engineering relies heavily on the efficient and rapid formation of blood vessels in the newly engineered tissues. To achieve this, it is crucial to use scaffolds that not only support the survival of vascular cells but also facilitate the development and maturation of a capillary network in vivo. Utilizing advanced biomaterials and scaffold designs is essential to ensure that the engineered tissues can integrate effectively with the host tissues and maintain their functionality over time. Here, we present a method for generating endothelial cells from induced pluripotent stem cells and pre-vascularizing scaffolds by seeding them with endothelial cells in a 3D porous structure. These pre-vascularized scaffolds can then be implanted in a rat subcutaneous model to create vascularized tissue constructs. This approach holds great promise for generating clinically viable constructs that can be used in regenerative medicine and drug development.
Indexed as
Identifiers
40208540What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.